128 related articles for article (PubMed ID: 36462597)
1. Oxineur, a novel peptide from Caspian cobra Naja naja oxiana against HT-29 colon cancer.
Sadat SN; Bagheri KP; Maghsoudi H; Shahbazzadeh D
Biochim Biophys Acta Gen Subj; 2023 Feb; 1867(2):130285. PubMed ID: 36462597
[TBL] [Abstract][Full Text] [Related]
2. The anti-rabies activity of Caspian cobra venom.
Farzad R; Gholami A; Hayati Roodbari N; Shahbazzadeh D
Toxicon; 2020 Oct; 186():175-181. PubMed ID: 32818494
[TBL] [Abstract][Full Text] [Related]
3. Proteome Analysis of Toxic Fractions of Iranian Cobra (Naja naja Oxiana) Snake Venom Using Two-Dimensional Electrophoresis and Mass Spectrometry.
Samianifard M; Nazari A; Tahoori F; Mohamadpour Dounighi N
Arch Razi Inst; 2021 Mar; 76(1):127-138. PubMed ID: 33818965
[TBL] [Abstract][Full Text] [Related]
4. The In Vitro Study of Anti-leishmanial Effect of Naja naja oxiana Snake Venom on Leishmania major.
Fallahi N; Shahbazzadeh D; Maleki F; Aghdasi M; Tabatabaie F; Khanaliha K
Infect Disord Drug Targets; 2020; 20(6):913-919. PubMed ID: 31903885
[TBL] [Abstract][Full Text] [Related]
5. Oxilipin, a New Anti-cancer Phospholipase A2-like Protein from Iranian Caspian Cobra,
Shekarabi SM; Parsian H; Pooshang Bagheri K; Shahbazzadeh D
Iran J Pharm Res; 2022 Dec; 21(1):e129616. PubMed ID: 36937210
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines.
Attarde SS; Pandit SV
BMC Complement Altern Med; 2017 Nov; 17(1):503. PubMed ID: 29183371
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Investigations of Two Pakistani
Manuwar A; Dreyer B; Böhmert A; Ullah A; Mughal Z; Akrem A; Ali SA; Schlüter H; Betzel C
Toxins (Basel); 2020 Oct; 12(11):. PubMed ID: 33105837
[TBL] [Abstract][Full Text] [Related]
8. Proteomic characterization of six Taiwanese snake venoms: Identification of species-specific proteins and development of a SISCAPA-MRM assay for cobra venom factors.
Liu CC; Lin CC; Hsiao YC; Wang PJ; Yu JS
J Proteomics; 2018 Sep; 187():59-68. PubMed ID: 29929037
[TBL] [Abstract][Full Text] [Related]
9. Comparative study of structure and activity of cytotoxins from venom of the cobras Naja oxiana, Naja kaouthia, and Naja haje.
Feofanov AV; Sharonov GV; Dubinnyi MA; Astapova MV; Kudelina IA; Dubovskii PV; Rodionov DI; Utkin YN; Arseniev AS
Biochemistry (Mosc); 2004 Oct; 69(10):1148-57. PubMed ID: 15527416
[TBL] [Abstract][Full Text] [Related]
10. Development of a human scFv antibody targeting the lethal Iranian cobra (Naja oxiana) snake venom.
Kazemi-Lomedasht F; Yamabhai M; Sabatier JM; Behdani M; Zareinejad MR; Shahbazzadeh D
Toxicon; 2019 Dec; 171():78-85. PubMed ID: 31622638
[TBL] [Abstract][Full Text] [Related]
11. Cobra (
Rayapati AM; Vemulapati B; Chanda C
J Biosci; 2024; 49():. PubMed ID: 38516910
[TBL] [Abstract][Full Text] [Related]
12. Expression and characterization of a novel recombinant cytotoxin II from Naja naja oxiana venom: A potential treatment for breast cancer.
Derakhshani A; Silvestris N; Hajiasgharzadeh K; Mahmoudzadeh S; Fereidouni M; Paradiso AV; Brunetti O; Atarod D; Safarpour H; Baradaran B
Int J Biol Macromol; 2020 Nov; 162():1283-1292. PubMed ID: 32562730
[TBL] [Abstract][Full Text] [Related]
13. Elapid snake venom analyses show the specificity of the peptide composition at the level of genera Naja and Notechis.
Munawar A; Trusch M; Georgieva D; Hildebrand D; Kwiatkowski M; Behnken H; Harder S; Arni R; Spencer P; Schlüter H; Betzel C
Toxins (Basel); 2014 Feb; 6(3):850-68. PubMed ID: 24590383
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory Activity of Caspian Cobra (Naja naja oxiana) Snake Venom on the Serum Level of Interleukin-27 and Histopathological Changes in Myelin Oligodendrocyte Glycoprotein-experimental Autoimmune Encephalomyelitisinduced Mice.
Mohammadnejad L; Zare Mirakabadi A; Oryan S; Jelodar Dezfouli S
Arch Razi Inst; 2021 Jan; 75(4):491-500. PubMed ID: 33403844
[TBL] [Abstract][Full Text] [Related]
15. Characterization of monoclonal antibodies against Naja naja oxiana neurotoxin I.
Stiles BG; Sexton FW; Guest SB; Olson MA; Hack DC
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):163-70. PubMed ID: 7945236
[TBL] [Abstract][Full Text] [Related]
16. Comparison of proteomic profiles of the venoms of two of the 'Big Four' snakes of India, the Indian cobra (Naja naja) and the common krait (Bungarus caeruleus), and analyses of their toxins.
Choudhury M; McCleary RJR; Kesherwani M; Kini RM; Velmurugan D
Toxicon; 2017 Sep; 135():33-42. PubMed ID: 28602829
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of an anti-hemorrhagic protein from Naja naja (Indian cobra) venom.
Suvilesh KN; Yariswamy M; Savitha MN; Joshi V; Nanjaraj Urs AN; Urs AP; Choudhury M; Velmurugan D; Vishwanath BS
Toxicon; 2017 Dec; 140():83-93. PubMed ID: 29107082
[TBL] [Abstract][Full Text] [Related]
18. Distinctive Distribution of Secretory Phospholipases A₂ in the Venoms of Afro-Asian Cobras (Subgenus:
Tan CH; Wong KY; Tan NH; Ng TS; Tan KY
Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30769779
[TBL] [Abstract][Full Text] [Related]
19. Elucidating the biogeographical variation of the venom of Naja naja (spectacled cobra) from Pakistan through a venom-decomplexing proteomic study.
Wong KY; Tan CH; Tan KY; Quraishi NH; Tan NH
J Proteomics; 2018 Mar; 175():156-173. PubMed ID: 29278784
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of three medically important Nigerian Naja (Naja haje, Naja katiensis and Naja nigricollis) snake venoms.
Adamude FA; Dingwoke EJ; Abubakar MS; Ibrahim S; Mohamed G; Klein A; Sallau AB
Toxicon; 2021 Jul; 197():24-32. PubMed ID: 33775665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
